This clinical study will measure the effectiveness of a new adjunctive treatment for people with type 1 diabetes.

  • sponsor
Updated on 23 November 2020


This clinical study will measure the effectiveness of a new adjunctive treatment for people with type 1 diabetes.


The purpose of this study is to evaluate the effectiveness of empagliflozin as a complimentary treatment to people with type 1 diabetes.

Qualified participants receive study-related medical care and study medication or placebo at no cost and may be compensated for time and travel.

Clinical Study IdentifierTX145867
Last Modified on23 November 2020


Yes No Not Sure

Inclusion Criteria

Ages Eligible for Study: 18 Years and older (Adult)
Genders Eligible for Study: Both
Patients must be diagnosed with type 1 diabetes
Participants must be using insulin
Patient must be located within 60 miles of CNS study location
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note